v3.20.2

Additional paid in capital (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2020

Dec. 31, 2019

Dec. 31, 2018

Stockholders' Equity Note [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity

	Six Months Ended			Year Ended
	June 30, 2020			December 31, 2019
		Weighted Average			Weighted Average
	Number of Options	Exercise Price		Number of Options	Exercise Price
Outstanding, beginning of period	5,236,401,500	$	0.003	5,014,851,500	$	0.002
Granted	30,500,000	$	0.035	254,050,000	$	0.028
Exercised	-	$	-	(26,000,000)	$	(0.003)
Cancelled / Expired	(13,500,000)	$	(0.034)	(6,500,000)	$	(0.015)
Outstanding, end of period	5,253,401,500	$	0.004	5,236,401,500	$	0.003
Exercisable, end of period	5,162,401,500	$	0.003	5,154,901,500	$	0.003

A summary of stock option activity is as follows:

	Year Ended			Year Ended
	December 31, 2019			December 31, 2018
		Weighted Average			Weighted Average
	Number of Options	Exercise Price		Number of Options	Exercise Price
Outstanding, beginning of period	5,014,851,500	$	0.002	4,963,851,500	$	0.002
Granted	254,050,000	$	0.028	52,500,000	$	0.015
Exercised	(26,000,000)	$	(0.003)	-	$	-
Cancelled	(6,500,000)	$	(0.015)	(1,500,000)	$	(0.015)
Outstanding, end of period	5,236,401,500	$	0.003	5,014,851,500	$	0.002
Exercisable, end of period	5,154,901,500	$	0.003	4,987,851,500	$	0.002

	Year Ended			Year Ended
	December 31, 2018			December 31, 2017
		Weighted Average			Weighted Average
	Number of Options	Exercise Price		Number of Options	Exercise Price
Outstanding, beginning of period	4,963,851,500	$	0.002	4,962,301,500	$	0.013
Granted	52,500,000	$	0.015	6,500,000	$	0.002
Cancelled	(1,500,000)	$	0.015	(4,950,000)	$	(0.061)
Outstanding, end of period	5,014,851,500	$	0.002	4,963,851,500	$	0.002
Exercisable, end of period	4,987,851,500	$	0.002	4,958,201,500	$	0.002

Schedule of Options Outstanding

		June 30, 2020						December 31, 2019
Expiry Date		Options	Exercise Price		Intrinsic Value			Options		Exercise Price				Intrinsic Value
May 30, 2020		-	$	-	$	-		10,000,000		$		0.035		$		-
July 1, 2021		4,365,001,300	$	0.002	$	0.037		4,365,001,300		$		0.002		$		0.015
November 27, 2022		6,950,000	$	0.015	$	0.024		7,200,000		$		0.015		$		0.002
January 31, 2023		40,500,000	$	0.015	$	0.024		40,500,000		$		0.015		$		0.002
June 13, 2023		5,000,000	$	0.015	$	0.024		5,000,000		$		0.015		$		0.002
October 1, 2023		300,000	$	0.050	$	-		300,000		$		0.050		$		-
February 3, 2024		10,000,000	$	0.035	$	0.004		10,000,000		$		0.035		$		-
March 14, 2024		9,150,000	$	0.035	$	0.004		9,150,000		$		0.035		$		-
April 12, 2024		560,000,200	$	0.002	$	0.037		560,000,200		$		0.002		$		0.015
April 12, 2024		3,900,000	$	0.015	$	0.024		4,150,000		$		0.015		$		0.002
April 12, 2024		200,000	$	0.030	$	0.009		200,000		$		0.030		$		-
May 6, 2024		13,000,000	$	0.035	$	0.004		13,000,000		$		0.035		$		-
May 17, 2024		40,000,000	$	0.050	$	-		40,000,000		$		0.050		$		-
May 17, 2024		25,400,000	$	0.035	$	0.004		27,900,000		$		0.035		$		-
June 17, 2024		5,000,000	$	0.050	$	-		5,000,000		$		0.050		$		-
June 17, 2024		5,000,000	$	0.035	$	0.004		5,000,000		$		0.035		$		-
August 16, 2024		2,500,000	$	0.050	$	-		2,500,000		$		0.050		$		-
September 6, 2024		1,000,000	$	0.050	$	-		1,000,000		$		0.050		$		-
September 17, 2024		5,000,000	$	0.035	$	0.004		5,000,000		$		0.035		$		-
October 3, 2024		3,500,000	$	0.035	$	0.004		3,500,000		$		0.035		$		-
October 24, 2024		2,000,000	$	0.035	$	0.004		2,000,000		$		0.035		$		-
December 11, 2024		120,000,000	$	0.015	$	0.024		120,000,000		$		0.015		$		0.002
April 1, 2025		10,000,000	$	0.035	$	0.004		-		$		-		$		-
May 31, 2025		20,000,000	$	0.035	$	0.004		-		$		-		$		-
Total		5,253,401,500	$	0.004	$	0.036		5,236,401,500		$		0.003		$		0.014
Weighted Average Remaining Contractual Life				1.48							1.96

The options outstanding at December 31, 2019 and 2018 were as follows:

		December 31, 2019												December 31, 2018
Expiry Date		Options		Exercise Price				Intrinsic Value						Options		Exercise Price				Intrinsic Value
April 18, 2019		-		$				$		-				200,000		$		0.030		$		0.005
May 21, 2019		-		$				$		-				500,000		$		0.015		$		0.020
July 25, 2019		-		$				$		-				1,000,000		$		0.015		$		0.020
August 1, 2019		-		$				$		-				1,250,000		$		0.015		$		0.020
January 30, 2020		-		$				$		-				2,400,000		$		0.015		$		0.020
May 29, 2020		-		$				$		-				560,000,200		$		0.002		$		0.033
May 30, 2020		10,000,000		$		0.035		$		-				-		$		-		$		-
July 1, 2021		4,365,001,300		$		0.002		$		0.015				4,390,001,300		$		0.002		$		0.033
November 27, 2022		7,200,000		$		0.015		$		0.002				7,200,000		$		0.015		$		0.020
January 31, 2023		40,500,000		$		0.015		$		0.002				47,000,000		$		0.015		$		0.020
June 13, 2023		5,000,000		$		0.015		$		0.002				5,000,000		$		0.015		$		0.020
October 1, 2023		300,000		$		0.050		$		-				300,000		$		0.050		$		-
February 3, 2024		10,000,000		$		0.035		$		-				-		$		-		$		-
March 14, 2024		9,150,000		$		0.035		$		-				-		$		-		$		-
April 12, 2024		560,000,200		$		0.002		$		0.015				-		$		-		$		-
April 12, 2024		4,150,000		$		0.015		$		0.002				-		$		-		$		-
April 12, 2024		200,000		$		0.030		$		-				-		$		-		$		-
May 6, 2024		13,000,000		$		0.035		$		-				-		$		-		$		-
May 17, 2024		40,000,000		$		0.050		$		-				-		$		-		$		-
May 17, 2024		27,900,000		$		0.035		$		-				-		$		-		$		-
June 17, 2024		5,000,000		$		0.050		$		-				-		$		-		$		-
June 17, 2024		5,000,000		$		0.035		$		-				-		$		-		$		-
August 16, 2024		2,500,000		$		0.050		$		-				-		$		-		$		-
September 6, 2024		1,000,000		$		0.050		$		-				-		$		-		$		-
September 17, 2024		5,000,000		$		0.035		$		-				-		$		-		$		-
October 3, 2024		3,500,000		$		0.035		$		-				-		$		-		$		-
October 24, 2024		2,000,000		$		0.035		$		-				-		$		-		$		-
December 11, 2024		120,000,000		$		0.015		$		0.002				-		$		-		$		-
Total		5,236,401,500		$		0.003		$		0.014				5,014,851,500		$		0.002		$		0.033
Weighted Average Remaining Contractual Life					1.96												2.40

		December 31, 2018						December 31, 2017
Expiry Date		Options	Exercise Price		Intrinsic Value			Options	Exercise Price		Intrinsic Value
April 18, 2019		200,000	$	0.030	$	0.005		-		-	$	-
May 21, 2019		500,000	$	0.015	$	0.020		500,000	$	0.030	$	0.01
July 25, 2019		1,000,000	$	0.015	$	0.020		1,000,000	$	0.015	$	0.025
August 1, 2019		1,250,000	$	0.015	$	0.020		1,250,000	$	0.015	$	0.025
January 30, 2020		2,400,000	$	0.015	$	0.020		2,400,000	$	0.015	$	0.025
May 29, 2020		560,000,200	$	0.002	$	0.033		560,000,200	$	0.002	$	0.038
July 1, 2021		4,390,001,300	$	0.002	$	0.033		4,390,001,300	$	0.002	$	0.038
November 27, 2022		7,200,000	$	0.015	$	0.020		8,700,000	$	0.015	$	0.025
January 31, 2023		47,000,000	$	0.015	$	0.020		-	$	-	$	-
June 13, 2023		5,000,000	$	0.015	$	0.020		-	$	-	$	-
October 1, 2023		300,000	$	0.050	$	-		-	$	-	$	-
Total		5,014,851,500	$	0.002	$	0.033		4,963,851,500	$	0.002	$	0.038
Weighted Average Remaining Contractual Life				2.40						3.38

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

		June 30, 2020				December 31, 2019
Risk-free interest rate			0.38	%			1.84	%
Expected life			4.9 Years				5 years
Expected dividends			0	%			0	%
Expected volatility			320	%			306	%
Forfeiture rate			0				0	%

The fair value of the stock options granted and vested was allocated as follows:

		December 31, 2019				December 31, 2018
Product development expense		$	1,243,644			$	186,476
Professional expense			392,677				401,151
Selling, general and administrative expenses			1,244,636				993,716
Interest			3,243,812				—
		$	6,124,769			$	1,581,343

			December 31, 2018		December 31, 2017
Product development expense		$	186,476	$	66,800
Professional expense			401,151		52,492
Selling, general and administration expenses:			993,716		80,938
		$	1,581,343	$	200,230

Schedule of Fair Value of Stock Options Granted-Allocation

		Three Months Ended June 30, 2020				Three Months Ended June 30, 2019				Six Months Ended June 30, 2020				Six Months Ended June 30, 2019
Interest expense		$	—			$	1,085,371			$	—			$	1,085,371
Product development			18,725				1,047,981				18,804				1,048,318
Professional			391,843				193,485				391,843				392,677
General, selling and administration			—				541,209				—				805,865
		$	410,568			$	2,868,046			$	410,647			$	3,332,231

Schedule Of Stock Based Compensation Expense

		December 31, 2019				December 31, 2018
Risk-free interest rate			1.84	%			2.52	%
Expected life			5 years				5 years
Expected dividends			0	%			0	%
Expected volatility			306	%			309	%
Forfeiture rate			0	%			0	%

	December 31, 2018		December 31, 2017
Risk-free interest rate	2.52%		2.34%
Expected life	5 years		5 years
Expected dividends	0%		0%
Expected volatility	309%		330%
Forfeiture rate	0%		0%

X

- References

No definition available.

+ Details

Name:	alrt_ScheduleOfStockBasedCompensationExpense
Namespace Prefix:	alrt_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Schedule of options outstanding.

+ References

No definition available.

+ Details

Name:	alrt_ScheduleofOptionsOutstanding
Namespace Prefix:	alrt_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration